Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 2:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 8,691 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Non Small Cell Lung Cancer, Small Cell Lung Cancer, Thymoma, Thymus Neoplasms
Interventions: Esophageal sparing IMRT; Radiation
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Thromboembolic Pulmonary Hypertension, CTEPH
Interventions: Riociguat, Placebo, Pulmonary endarterectomy; Drug · Procedure
Lead sponsor: International CTEPH Association; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Stroke, Parkinson Disease, Multiple Sclerosis, Oropharyngeal Dysphagia, Alzheimer Disease, Dementia
Interventions: Dysphagia Detection System; Device
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 12
States / cities: Downey, California • Aurora, Colorado • Washington D.C., District of Columbia + 8 more

Conditions: Cardiac Arrest, Out-Of-Hospital
Interventions: CPR Training, CPR Manikin Type; Behavioral · Device
Lead sponsor: University of Nevada, Reno; Other
Eligibility: Not listed
Enrollment: 2,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: SARS CoV 2 Infection, COVID-19
Interventions: Pfizer/BioNTech (BNT162b2), Moderna; Biological
Lead sponsor: DHR Health Institute for Research and Development; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Brownsville, Texas • Edinburg, Texas • Rio Grande City, Texas

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Tirasemtiv, Placebo tablets; Drug
Lead sponsor: Cytokinetics; Industry
Eligibility: 18 Years and older
Enrollment: 744 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 49
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 42 more

Conditions: Levator Ani Syndrome With Pain and/or Constipation Symptoms.
Interventions: Biofeedback therapy, Botulinum Toxin Type A Injection; Behavioral · Procedure
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Diabetes type1
Interventions: AG019 - Low Dose, Teplizumab, Placebo-AG019, Placebo-Teplizumab, AG019 - High Dose; Biological · Drug
Lead sponsor: Precigen Actobio T1D, LLC; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 15
States / cities: Birmingham, Alabama • San Francisco, California • Ventura, California + 12 more

Conditions: Injuries, Shock, Traumatic
Interventions: normal saline control, vasopressin; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Nuclear Sclerosis of the Lens, Posterior Subcapsular Cataract, Cortical Cataract
Interventions: Femtosecond Laser Assisted Cataract Surgery w/ Catalys Laser, Femtosecond Laser Assisted Cataract Surgery w/ LenSx Laser; Procedure
Lead sponsor: Steven H. Linn, OD; Other
Eligibility: 22 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Low Back Pain, Lumbago, Spinal Instability
Interventions: Video, Handout; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Sleep Apnea, Obstructive
Interventions: Coblation (radiofrequency-based device); Device
Lead sponsor: ArthroCare Corporation; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Renal Insufficiency, Chronic
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 79 Years
Enrollment: 5,499 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2028
U.S. locations: 12
States / cities: Oakland, California • San Francisco, California • Chicago, Illinois + 6 more

Conditions: Airway Obstruction, Snoring, Sedation Complication
Interventions: Anti-snoring device, No anti -snoring device during their procedure.; Device · Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Renal Malignant Tumor
Interventions: Contrast enhanced ultrasound with Lumason; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Physical Disability, Quality of Life, Social Interaction, Health, Subjective
Interventions: No intervention; Other
Lead sponsor: Allina Health System; Other
Eligibility: 5 Years to 10 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Golden Valley, Minnesota

Conditions: Aging, Mortality, All-cause Mortality, Life Expectancy, Cardiovascular Diseases, Neoplasms, Cognitive Dysfunction, Metabolic Syndrome, Frailty, Musculoskeletal Disease, Neurodegenerative Disease, Dementia, Activities of Daily Living, Health Related Quality of Life, Environmental Exposure, Occupational Diseases, Health Equity, Social Determinants of Health, Physical Disability
Interventions: Multi-Domain Ecological and Clinical Data Linkage; Other
Lead sponsor: Longevity Metrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2099
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Obesity
Interventions: AGBS; Device
Lead sponsor: Allurion Technologies; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 17
States / cities: Scottsdale, Arizona • Los Angeles, California • Aurora, Colorado + 14 more

Conditions: Autoimmune Hepatitis
Interventions: LCP-Tacro (tacrolimus), Azathioprine; Drug
Lead sponsor: Asahi Kasei Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 8
States / cities: Phoenix, Arizona • Jacksonville, Florida • Chicago, Illinois + 5 more

Conditions: Colorectal Cancer
Interventions: Irinotecan, CyberKnife; Drug · Radiation
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Park Ridge, Illinois

Conditions: Major Depressive Disorder, Suicide, Attempted
Interventions: Not listed
Lead sponsor: Van Andel Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Acute Pain, Brachial Plexus Block
Interventions: Group 1 In-plane, Group 2 out of plane; Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: Galveston, Texas • League City, Texas

Conditions: Prostate Cancer
Interventions: ClariCore System; Device
Lead sponsor: Precision Biopsy, Inc.; Industry
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Baltimore, Maryland • New York, New York

Conditions: Breast Neoplasms
Interventions: Sentinel Lymph Node Biopsy; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)

Videofluoroscopic Swallowing Study (VFSS)

Gathering Evidence on Best Practices for Lay Rescuer CPR Training

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Low Dose Vasopressin in Traumatic Shock

The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.

Home Program Education for Patients With Low Back Pain

Study to Evaluate Recovery From Postoperative Pain After Sleep Apnea Surgery

SDCC - Prospective Cohort Study of Chronic Renal Insufficiency

Anti-Snoring Appliances and Airway Manipulation in Patients Undergoing Anesthetic Sedation

Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)

PLAY LONG: The Effect of Sports and Recreation Participation for Young chiLdren With physicAl disabilitY

Human Observatory Study

The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)

LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

A Longitudinal Study of Inflammatory Pathways in Depression

Out of Plane Approach for Interscalene

ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy

Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy